Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years

JAMA
December 7, 2021, Vol 326, No. 21, Pages 2105-2223
https://jamanetwork.com/journals/jama/currentissue

 

Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years
Noa Eliakim-Raz, MD; Yaara Leibovici-Weisman, MD; Amos Stemmer, MD; et al.
free access has active quiz
JAMA. 2021;326(21):2203-2204. doi:10.1001/jama.2021.19885
This study assesses antispike (anti-S) IgG antibody titers before and after a third BNT162b2 dose (booster) in individuals aged 60 years and older in Israel.